Clinical Trial: A Clinical Investigation of MINIVISC(R) PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC)

U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07184437) titled 'A Clinical Investigation of MINIVISC(R) PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC)' on Aug. 06, 2024.

Brief Summary: A clinical investigation to confirm the clinical safety and performance of OVD-F device MINIVISC(R) PLUS 1.4 % for cataract surgery and implantation of intraocular lenses, glaucoma surgery, anterior segment surgery and corneal transplantation.

Study Start Date: Feb. 20, 2024

Study Type: INTERVENTIONAL

Condition: Cataract

Intervention: DEVICE: OVD-F...